Janux Therapeutics News

Janux Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 8 16:53 ET

Janux Therapeutics | 10-K: Annual report

Mar 8 16:26 ET

Janux Therapeutics | 8-K: Janux Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights

Mar 8 16:16 ET

Janux Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(19.99%),Peter Kolchinsky(19.99%), etc.

Mar 6 18:55 ET

Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director RA CAPITAL MANAGEMENT, L.P.

Mar 6 16:23 ET

Janux Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Jay Lichter, Ph.D.(17.1%),Tighe Reardon(10.4%), etc.

Mar 4 20:11 ET

Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Avalon Ventures XI, L.P.

Mar 4 19:36 ET

Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Gujrathi Sheila

Mar 4 16:47 ET

Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director CAPPS VICKIE L

Mar 4 16:37 ET

Janux Therapeutics | 424B5: Prospectus

Feb 29 17:35 ET

Janux Therapeutics | 8-K: Current report

Feb 29 17:14 ET

Janux Therapeutics | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses

Feb 29 06:09 ET

Janux Therapeutics | 8-K: Current report

Feb 28 17:31 ET

Janux Therapeutics | 424B5: Prospectus

Feb 28 13:27 ET

Janux Therapeutics | 8-K: Current report

Feb 27 17:27 ET

Janux Therapeutics | 8-K: Current report

Feb 26 22:23 ET

Janux Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-EcoR1 Capital, LLC(0%),Oleg Nodelman(0%), etc.

Feb 14 17:58 ET

Janux Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Citadel Advisors LLC(6.8%),Citadel Advisors Holdings LP(6.8%), etc.

Feb 14 17:06 ET

Janux Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BVF Partners L.P.(9.9%),BVF Inc.(9.9%), etc.

Feb 14 09:47 ET

Janux Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-David Campbell, Ph.D.(5.3%)

Feb 9 16:38 ET